Results 41 to 50 of about 28,908 (228)

Severe L-asparaginase-induced Hypertriglyceridaemia Treated with Plasmapheresis [PDF]

open access: yes, 2021
L-asparaginase is used for the treatment of acute lymphoblastic leukaemia. Hypertriglyceridaemia is a side effect and associated with potentially fatal complications, including acute pancreatitis.
Tavares, Isabel   +3 more
core   +1 more source

Plasmapheresis: Is it a potential alternative treatment for chronic urticaria? /

open access: yes, 2022
Background: Chronic urticaria is a common disease. Plasmapheresis is an alternative treatment that can be appropriate for patients who are resistant to treatment with 2nd generation antihistamines or for whom treatment with omalizumab is unsuitable ...
Chomičienė, Anželika,   +3 more
core   +1 more source

Reducing the economic burden in management of Guillain–Barre syndrome using modified plasmapheresis

open access: yesAsian Journal of Transfusion Science, 2016
Background: Guillain–Barre syndrome (GBS) is an autoimmune acute inflammatory demyelinating polyneuropathy affecting the peripheral nervous system treated with high-dose immunoglobulin, physical therapy, or plasmapheresis.
Rekha Ramaswamy Iyer   +3 more
doaj   +1 more source

Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients

open access: yesKorean Journal of Transplantation, 2020
The role of the isoagglutinin (IA) titer in liver transplantation (LT) is still not well defined, but the general belief is that a higher titer may result in a higher risk of rejection in ABO-incompatible living donor LT.
Boram Lee   +5 more
doaj   +1 more source

Source Plasma Donation: The Experience of the Iranian Blood Transfusion Organization

open access: yesInternational Journal of Hematology-Oncology and Stem Cell Research, 2022
Background: A declining need for red blood cells coupled with strengthening demand for plasma-derived medicines has led to a strong focus on moving whole blood donors to plasmapheresis. The purpose of this study was to evaluate the four-year policies of
Saeed Mohammadi   +5 more
doaj  

Association of regular plasmapheresis donation with serum protein and electrolyte levels: a multicentre cross-sectional study in China

open access: yesBMJ Open
Background China’s plasmapheresis donation policy differs from that of Western countries. The association between regular plasmapheresis donation and donor health in China is still unknown.Objectives To investigate the association of regular ...
Yu Zhang   +13 more
doaj   +1 more source

Recruiting and retaining plasmapheresis donors: A critical belief analysis

open access: yes, 2015
This paper identifies critical beliefs underpinning intentions to commence and continue plasmapheresis donation. Whole blood (n = 624) and first-time plasmapheresis (n = 460) donors completed a cross-sectional survey assessing the belief-base of the ...
Starfelt, Louise C.   +7 more
core   +1 more source

Plasmapheresis in Neonatal Lupus

open access: yes, 2022
About 2% of mothers with Sjögren’s syndrome and about 1% of mothers with systemic lupus erythematosus deliver a baby with a congenital heart block (CHB).
Angelica S. J. Scribner   +2 more
core   +1 more source

Bone density and bone metabolism in plasmapheresis donors

open access: yesZhongguo shuxue zazhi
Objective To investigate the level of serum bone metabolism and biochemical markers and bone density of plasmapheresis donors, and to provide scientific basis for ensuring the health and safety of plasmapheresis donors in China.
Wan LI   +5 more
doaj   +1 more source

Application of biological age assessment of Chinese population in potential anti-ageing technology

open access: yesImmunity & Ageing, 2018
Background This study aimed to construct a biological age assessment formula for the Chinese population and to explore the effectiveness of double filtration plasmapheresis for anti-ageing and longevity. Methods 915 subjects were recruited, including 584
Xufeng Li   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy